跳至主要内容
临床试验/JPRN-UMIN000003381
JPRN-UMIN000003381招募中未知

A feasibility study of adjuvant therapy with UFT/LV plus oxaliplatin following curative resection for stage III colorectal cancer - A feasibility study of adjuvant therapy with TEGAFOX following curative resection for stage III colorectal cancer

Toho University School of Medicine0 个研究点目标入组 45 人开始时间: 2010年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Multiple malignancies within five years 2) Other severe complications, such as pulmonary emphysema, pulmonary fibrosis, hyper pulmonary emphysema,paralysis intestinal, intestinal obstruction, uncontrolable diabetes, cirrhosis, uncontrollable hypertension, myocardial infarction within six months, angina. 3)Diarrhea 4) Pregnant 5)Evidence of psychiatric disability interfering with enrollment to clinical trial 6)Patients judged inappropriate for this study by physicians

研究者

发起方
Toho University School of Medicine

相似试验